Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUNRISE-PD: NE3107 in Early Parkinson's Disease
NCT06757010Phase 2Completed
- Sponsor
- BioVie
- Start
- Mar 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bezisterim in Parkinson's disease (PD), sponsored by BioVie. Started Mar 2025; status: completed.
02
Drugs
bezisterim
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06757010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06757010.